Browsing by Author Moreau, P. (Philippe)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleTypeAuthor(s)
2019A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisArticuloWalker, B.A. (Brian A.); Mavrommatis, K. (Konstantinos); Wardell, C.P. (Christopher P.); Ashby, T.C. (T. Cody); Bauer, M. (Michael); Davies, F. (Faith); Rosenthal, A. (Adam); Wang, H. (Hongwei); Qu, P. (Pingping); Hoering, A. (Antje); Samur, M. (Mehmet); Towfic, F. (Fadi); Ortiz, M. (María); Flynt, E. (Erin); Yu, Z. (Zhinuan); Yang, Z. (Zhihong); Rozelle, D. (Dan); Obenauer, J. (John); Trotter, M. (Matthew); Auclair, D. (Daniel); Keats, J.J. (Jonathan J.); Bolli, N. (Niccolo); Fulciniti, M. (Mariateresa); Szalat, R. (Raphael); Moreau, P. (Philippe); Durie, B. (B.); Stewart, A.K. (A. Keith); Goldschmidt, H. (Hartmut); Raab, M.S. (Marc S.); Einsele, H. (Hermann); Sonneveld, P. (Pieter); San-Miguel, J.F. (Jesús F.); Lonial, S. (Sagar); Jackson, G.H. (Graham H.); Anderson, K.C. (K.C.); Avet-Loiseau, H. (Herve); Munshi, N.C. (Nikhil C.); Thakurta, A. (Anjan); Morgan, G.J. (Gareth J.)
2020A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trialArticuloFacon, T. (Thierry); Dimopoulos, M.A. (Meletios A.); Meuleman, N. (Nathalie); Belch, A. (Andrew); Mohty, M. (Mohamad); Chen, W. (Wen-Ming); Kim, K. (Kihyun); Zamagni, E. (Elena); Rodriguez-Otero, P. (Paula); Renwick, W. (William); Rose, C. (Christian); Tempescul, A. (Adrian); Boyle, E. (Eileen); Manier, S. (Salomon); Attal, M. (Michel); Moreau, P. (Philippe); Macro, M. (Margaret); Leleu, X. (Xavier); Chretien, M.L. (Marie Lorraine); Ludwig, H. (Heinz); Guo, S. (Shien); Sturniolo, M. (Michael); Tinel, A. (Antoine); Monzini, M.S. (Mara Silvia); Costa, B. (Bruno); Houck, V. (Vanessa); Hulin, C. (Cyrille); Mary, J.Y. (Jean Yves)
2018Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectArticuloUsmani, S.Z. (Saad Z.); Hoering, A. (Antje); Cavo, M. (Michele); San-Miguel, J.F. (Jesús F.); Goldschimdt, H. (Hartmut); Hajek, R. (R.); Turesson, I. (Ingemar); Lahuerta, J.J. (Juan José); Attal, M. (Michele); Barlogie, B. (Bart); Lee, J.H. (Jae Hoon); Kumar, S. (Shaji); Lenhof, S. (Stig); Morgan, G.J. (Gareth J.); Rajkumar, S.V. (S. Vincent); Durie, B. (B.); Moreau, P. (Philippe)
2023Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUSOtrosMoreau, P. (Philippe); Chari, A. (Ajai); Oriol, A. (Albert); Martínez-López, J. (Joaquín); Haenel, M. (Mathias); Touzeau, C. (Cyrille); Ailawadhi, S. (Sikander); Besemer, B. (Britta); Rubia-Comos, J. (Javier) de la; Encinas, C. (Cristina); Mateos, M.V. (María Victoria); Salwender, H. (Hans); Rodriguez-Otero, P. (Paula); Hulin, C. (Cyrille); Karlin, L. (Lionel); Sureda-Balari, A. (Anna); Bargay, J. (Joan); Benboubker, L. (Lotfi); Rosiñol, L. (Laura); Tarantolo, S. (Stefano); Terebelo, H. (Howard); Yang, S. (Shiyi); Wang, J. (Jianping); Nnane, I. (Ivo); Qi, M. (Ming); Kosh, M. (Michele); Delioukina, M. (Maria); Goldschmidt, H. (Hartmut)
2020Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUXArticuloKaufman, J.L. (Jonathan L.); Dimopoulos, M.A. (Meletios A.); White, D.J. (Darrell J.); Benboubker, L. (Lotfi); Cook, G. (Gordon); Leiba, M. (Merav); Morton, J. (James); Takezako, N. (Naoki); Kim, K. (Kihyun); Moreau, P. (Philippe); Sutherland, H.J. (Heather J.); Magen, H. (Hila); Iida, S. (Shinsuke); Kim, J.S. (Jin Sheok); Prince, H.M. (H. Miles); Cochrane, T. (Tara); Oriol, A. (Albert); O’Rourke, L. (Lisa); Trivedi, S. (Sonali); Casneuf, T. (Tineke); Krevvata, M. (Maria); Ukropec, J. (Jon); Kobos, R. (Rachel); Avet-Loiseau, H. (Herve); Usmani, S.Z. (Saad Z.); San-Miguel, J.F. (Jesús F.)
2020Daratumumab plus lenalidomide and dexamethasone in relapsed/ refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 studyArticuloBahlis, N.J. (Nizar J.); Dimopoulos, M.A. (Meletios A.); White, D.J. (Darrell J.); Benboubker, L. (Lotfi); Cook, G. (Gordon); Leiba, M. (Merav); Ho, P.J. (P. Joy); Kim, K. (Kihyun); Takezako, N. (Naoki); Moreau, P. (Philippe); Kaufman, J.L. (Jonathan L.); Krevvata, M. (Maria); Chiu, C. (Christopher); Qin, X. (Xiang); Okonkwo, L. (Linda); Trivedi, S. (Sonali); Ukropec, J. (Jon); Qi, M. (Ming); San-Miguel, J.F. (Jesús F.)
2018Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelArticuloCaers, J. (Jo); Paiva, B. (Bruno); Zamagni, E. (Elena); Leleu, X. (Xavier); Bladé, J. (Joan); Kristinsson, S.Y. (S. Y.); Touzeau, C. (C.); Abildgaard, N. (N.); Terpos, E. (Evangelos); Heusschen, R. (R.); Ocio, E.M. (Enrique M.); Delforge, M. (M.); Sezer, O. (O.); Beksac, M. (Meral); Ludwig, H. (Heinz); Merlini, G. (G.); Moreau, P. (Philippe); Zweegman, S. (Sonja); Engelhardt, M. (Monika); Rosiñol, L. (Laura)
2023Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantationArticuloOcio, E.M. (Enrique M.); Perrot, A. (Aurore); Bories, P. (Pierre); San-Miguel, J.F. (Jesús F.); Blau, I.W. (Igor W.); Karlin, L. (Lionel); Martínez-López, J. (Joaquín); Wang, S.Y. (Song Yau); Bringhen, S. (Sara); Marcatti, M. (Magda); Mateos, M.V. (María Victoria); Rodriguez-Otero, P. (Paula); Oliva, S. (Stefania); Nogai, A. (Axel); Le-Roux, N. (Nadia); Dong, L. (Liyan); Mace, S. (Sandrine); Gassiot, M. (Matthieu); Fitzmaurice, T. (Thomas); Oprea, C. (Corina); Moreau, P. (Philippe)
2020Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 studyArticuloDimopoulos, M.A. (Meletios A.); Lonial, S. (Sagar); White, D.J. (Darrell J.); Moreau, P. (Philippe); Weisel, K. (Katja); San-Miguel, J.F. (Jesús F.); Shpilberg, O. (Ofer); Spicka, I. (Ivan); Walter-Croneck, A. (Adam); Magen, H. (Hila); Mateos, M.V. (María Victoria); Belch, A. (Andrew); Reece, D. (Donna); Beksac, M. (Meral); Spencer, A. (Andrew); Oakervee, H. (Heather); Orlowski, R.Z. (Robert Z.); Shpilberg, O. (Ofer); Taniwaki, M. (Masafumi); Röllig, C. (Christoph); Einsele, H. (Hermann); Matsumoto, M. (Morio); Wu, K.L. (Ka Lung); Anderson, K. (Kenneth C.); You, Y.M. (Ying-Ming); Ganetsky, A. (Alex); Singhal, A.K. (Anil K.); Richardson, P.G. (Paul G.)
2018Insights on multiple myeloma treatment strategiesArticuloMateos, M.V. (María Victoria); Ludwig, H. (Heinz); Bazarbachi, A. (Ali); Beksac, M. (Meral); Bladé, J. (Joan); Boccadoro, M. (Mario); Cavo, M. (Michele); Delforge, M. (M.); Dimopoulos, M.A. (Meletios A.); Facon, T. (Thierry); Geraldes, C. (Catarina); Goldschmidt, H. (Hartmut); Hajek, R. (R.); Hansson, M. (Markus); Jamroziak, K. (Krzysztof); Leiba, M. (Merav); Masszi, T. (Tamás); Mendeleeva, L. (Larisa); O’Dwyer, M. (Michael); Plesner, T. (Torben); San-Miguel, J.F. (Jesús F.); Straka, C. (Christian); Donk, N.W.C.J. (Niels W.C.J.) van de; Yong, K. (Kwee); Zver, S. (Samo); Moreau, P. (Philippe); Sonneveld, P. (Pieter)
2018Interpreting clinical trial data in multiple myeloma: translating findings to the real-world settingArticuloRichardson, P.G. (Paul G.); San-Miguel, J.F. (Jesús F.); Moreau, P. (Philippe); Hajek, R. (R.); Dimopoulos, M.A. (Meletios A.); Laubach, J.P. (Jacob P.); Palumbo, A. (Antonio); Luptakova, K. (Katarina); Cessario, R. (Romanus); Romanus, D. (Dorothy); Skacel, T. (Tomas); Kumar, S. (Shaji); Anderson, K. (Kenneth C.)
2005Linking Two Immuno-Suppressive Molecules: Indoleamine 2,3 Dioxygenase Can Modify HLA-G Cell-Surface Expression1ArticuloGonzalez-Hernandez, A. (Alvaro); LeMaoult, J. (Joël); Lopez-Picazo, A. (Ana); Alegre-Martinez, E. (Estibaliz); Caumartin, J. (Julien); Le-Rond, S. (Solene); Daouya, M. (Marina); Moreau, P. (Philippe); Carosella, E.D. (Edgardo D.)
2023Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)RevisionTerpos, E. (Evangelos); Engelhardt, M. (Monika); Delforge, M. (M.); Cook, G. (Gordon); Gay, F. (Francesca); Donk, N.W.C.J. (Niels W.C.J.) van de; Ntanasis-Stathopoulos, I. (Ioannis); Vangsted, A.J. (Annette Juul); Driessen, C. (Cristoph); Schjesvold, F.H. (Fredrik H.); Zweegman, S. (Sonja); Hajek, R. (R.); Moreau, P. (Philippe); Einsele, H. (Hermann); San-Miguel-Izquierdo, J. (Jesús Fernando); Boccadoro, M. (Mario); Dimopoulos, M.A. (Meletios A.); Sonneveld, P. (Pieter); Ludwig, H. (Heinz)
2023Overall survival with daratumumab, lenalidomide, and dexamethasone in previously treated multiple myeloma (POLLUX): a randomized, open-label, phase III trialArticuloDimopoulos, M.A. (Meletios A.); Oriol, A. (Albert); Nahi, H. (Hareth); San-Miguel-Izquierdo, J. (Jesús Fernando); Bahlis, N.J. (Nizar J.); Usmani, S.Z. (Saad Z.); Rabin, N. (Neil); Orlowski, R.Z. (Robert Z.); Suzuki, K. (Kenshi); Plesner, T. (Torben); Yoon, S.S. (Sung-Soo); Ben-Yehuda, D. (Dina); Richardson, P.G. (Paul G.); Goldschmidt, H. (Hartmut); Reece, D. (Donna); Ahmadi, T. (Tahamtan); Qin, X. (Xiang); Garvin-Mayo, W. (Wendy); Gai, X. (Xue); Carey, J. (Jodi); Carson, R. (Robin); Moreau, P. (Philippe)
2018Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma NetworkArticuloLudwig, H. (Heinz); Delforge, M. (M.); Facon, T. (Thierry); Einsele, H. (Hermann); Gay, F. (Francesca); Moreau, P. (Philippe); Avet-Loiseau, H. (Herve); Boccadoro, M. (Mario); Hajek, R. (R.); Mohty, M. (Mohamad); Cavo, M. (Michele); Dimopoulos, M.A. (Meletios A.); San-Miguel, J.F. (Jesús F.); Terpos, E. (Evangelos); Zweegman, S. (Sonja); Garderet, L. (Laurent); Mateos, M.V. (María Victoria); Cook, G. (Gordon); Leleu, X. (Xavier); Goldschmidt, H. (Hartmut); Jackson, G.H. (Graham H.); Kaiser, M. (Martin); Weisel, K. (Katja); Donk, N.W.C.J. (Niels W.C.J.) van de; Waage, A. (Anders); Beksac, M. (Meral); Mellqvist, U. (Ulf); Engelhardt, M. (Monika); Caers, J. (Jo); Driessen, C. (Cristoph); Bladé, J. (Joan); Sonneveld, P. (Pieter)
2018Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working GroupArticuloMoulopoulos, L.A. (Lia A.); Koutoulidis, V. (Vassilis); Hillengass, J. (Jens); Zamagni, E. (Elena); Aquerreta, J.D. (Jesús D.); Roche, C.L. (Charles L.); Lentzsch, S. (Suzanne); Moreau, P. (Philippe); Cavo, M. (Michele); San-Miguel, J.F. (Jesús F.); Dimopoulos, M.A. (Meletios A.); Rajkumar, S.V. (S. Vincent); Durie, B. (B.); Terpos, E. (Evangelos); Delorme, S. (Stefan)